What are insomnia remission rates after accessible CBT-I formats?

How often do people actually reach remission?

The most concrete number comes from the shortest format: a one-time, four-hour CBT-I workshop taught by a health educator. One in five participants (20%) met criteria for insomnia remission afterward, and about 35.6% showed some other meaningful improvement [5]. That is a modest remission rate, but it comes from a single session rather than a full course of treatment, which makes it a useful floor for what very low-burden formats can achieve.

Digital formats report remission rates in line with other digital CBT-I programs. An app-based CBT-I course found remission comparable to established digital programs such as Ritterband's [4], and a guided digital program for people with insomnia plus psychological distress reported clinical response and remission rates comparable to existing benchmarks [3]. The pattern is that adding structure and guidance, whether through an app or a guided program, tends to sit in the same range as other digital offerings rather than dramatically outperforming them.

These figures are not directly comparable to each other. The workshop counted remission among community adults [5], the app trial among people using a self-directed course [4], and the guided program among adults with insomnia and psychological distress [3]. Different starting populations and different remission definitions mean the percentages describe different groups, so the honest summary is a range rather than a single rate.

Why remission, not just symptom relief, is the outcome that matters

Remission is more than feeling a bit better. In a randomized trial of 658 adults with insomnia disorder, digital CBT-I reduced suicidal ideation among people who had it at the start, and about half of that effect was estimated to run through insomnia remission [1]. In other words, getting sleep into remission appears to be part of how the treatment reduces suicidal thoughts, not a side benefit.

The same trial found a prevention signal. Among people without suicidal ideation at baseline, CBT-I did not directly stop new suicidal thoughts from appearing, but people who reached insomnia remission had lower rates of new-onset suicidal ideation than those who did not (1.5% vs 6.5%) [1]. That is an association within a trial, not proof that remission causes the prevention, but it is consistent with remission being the active ingredient.

This is why remission rates deserve attention even when they look unspectacular. A 20% remission rate from a four-hour workshop [5] means a meaningful minority of people get a durable reset from a very low-cost intervention, and for those people the downstream benefits may extend beyond sleep.

Who is more or less likely to reach remission?

Not everyone responds equally. In a study of CBT-I for people with insomnia and a major depressive episode, treatment-resistant depression predicted less improvement in insomnia severity, and shorter sleep duration predicted a less favorable response along with less improvement in daytime dysfunction and sleep-related worry [2]. People whose depressive symptoms and sleep fluctuated with the seasons, or who had daytime dysfunction, tended to do better, especially for early-morning awakening insomnia [2].

That study used a four-session weekly CBT-I format compared against sleep education, so it speaks to a brief, accessible course rather than a long clinical program [2]. The takeaway is that accessible CBT-I is not one-size-fits-all: a person's depression history and baseline sleep length appear to shift how much they gain, which is useful context when interpreting any headline remission rate.

What should a curious reader conclude?

Accessible CBT-I, whether a single workshop, an app, or a guided digital program, produces remission for a real share of participants, with the workshop figure around 20% [5] and digital programs reporting rates comparable to other digital CBT-I offerings [3][4]. The evidence does not support a single precise remission rate across formats, because the populations and definitions differ.

The stronger and more consistent finding is that remission is worth pursuing. In the largest trial here, insomnia remission accounted for roughly half of digital CBT-I's effect on suicidal ideation and was associated with fewer new cases of suicidal thinking [1]. For a reader weighing whether a low-burden format is worth trying, the message is that even modest formats can move people into remission, and remission is where much of the broader benefit appears to concentrate.

Sources used in this answer

Related research questions